Published in Br J Cancer on February 23, 2004
Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem (2008) 1.49
Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistance. Sci Rep (2013) 0.77
Cell membrane modulation as adjuvant in cancer therapy. Cancer Treat Rev (2016) 0.76
Rapid Identification of Chemoresistance Mechanisms Using Yeast DNA Mismatch Repair Mutants. G3 (Bethesda) (2015) 0.76
A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res (1987) 10.80
Endocytosis and molecular sorting. Annu Rev Cell Dev Biol (1996) 8.83
Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol (1998) 4.94
Mammalian ABC transporters in health and disease. Annu Rev Biochem (2001) 4.90
Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell (1993) 4.76
The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol (2001) 4.57
Cholesterol, lipid rafts, and disease. J Clin Invest (2002) 4.05
The anthracyclines: will we ever find a better doxorubicin? Semin Oncol (1992) 3.28
How proteins move lipids and lipids move proteins. Nat Rev Mol Cell Biol (2001) 3.26
MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell (1996) 2.87
Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry (2002) 2.59
Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J (2003) 2.06
Sphingoid base signaling via Pkh kinases is required for endocytosis in yeast. EMBO J (2001) 2.02
Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry (1998) 2.00
Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J Biol Chem (2002) 1.94
The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J Biol Chem (2000) 1.73
The mechanism of inhibition of Ran-dependent nuclear transport by cellular ATP depletion. J Cell Biol (2002) 1.59
Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia. Methods Enzymol (1995) 1.54
Cyclodextrin-mediated removal of sterols from monolayers: effects of sterol structure and phospholipids on desorption rate. Biochemistry (1996) 1.48
Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest (1997) 1.48
Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest (2000) 1.32
Quantitative contributions of cholesterol and the individual classes of phospholipids and their degree of fatty acyl (un)saturation to membrane fluidity measured by fluorescence polarization. Biochemistry (1987) 1.25
Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv Lipid Res (1993) 1.19
ABC transporters in cellular lipid trafficking. Curr Opin Lipidol (2000) 1.12
A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem J (2001) 1.09
Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane. Biochemistry (1994) 1.08
Flip-flop of doxorubicin across erythrocyte and lipid membranes. Biochem Pharmacol (1997) 0.92
Differential expression of sphingolipids in MRP1 overexpressing HT29 cells. Int J Cancer (2000) 0.92
Internalization and sorting of plasma membrane sphingolipid analogues in differentiating oligodendrocytes. J Neurochem (1999) 0.92
Role of anionic phospholipids in the interaction of doxorubicin and plasma membrane vesicles: drug binding and structural consequences in bacterial systems. Biochemistry (1993) 0.91
Metabolism and apoptotic properties of elevated ceramide in HT29rev cells. Biochem J (1998) 0.87
Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs. J Pharm Sci (1984) 0.87
Pharmacokinetics and metabolism of anthracyclines. Cancer Surv (1993) 0.86
Reversal of multidrug resistance and increase in plasma membrane fluidity in CHO cells with R-verapamil and bile salts. Eur J Cancer (2001) 0.82
Interaction of liposome formulations with human skin in vitro. Int J Pharm (2001) 0.80
The anionic phospholipid-mediated membrane interaction of the anti-cancer drug doxorubicin is enhanced by phosphatidylethanolamine compared to other zwitterionic phospholipids. Biochemistry (1997) 0.79
In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells. Eur J Cancer Clin Oncol (1988) 0.79
Changes in plasma membrane fluidity of immortal rodent cells induced by anticancer drugs doxorubicin, aclarubicin and mitoxantrone. Cell Biol Int (1999) 0.78
A role for plasma membrane potential in doxorubicin--induced cytotoxicity. Anticancer Res (1992) 0.76
Sphingomyelin content conditions insertion of daunorubicin within phosphatidylcholine monolayers. FEBS Lett (2002) 0.76
Growth-related expression of ribosomal protein genes in Saccharomyces cerevisiae. Mol Gen Genet (1993) 14.93
Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell (1995) 3.02
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 2.31
Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. Biochem J (1992) 2.10
Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J (1992) 1.97
A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J Biol Chem (1993) 1.74
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.68
Phosphatidic acid activation of protein kinase C-zeta overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. Biochem J (1994) 1.64
Purification, cDNA-cloning and expression of human diacylglycerol kinase. FEBS Lett (1990) 1.45
Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology. J Cell Biol (2000) 1.38
The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett (1994) 1.34
The biologically active phospholipid, lysophosphatidic acid, induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D. Comparison with the response to endothelin. Biochem J (1992) 1.33
Protein kinase Czeta is a negative regulator of protein kinase B activity. J Biol Chem (1999) 1.29
Isolation of plasma membranes from rat and mouse livers and hepatomas. Methods Enzymol (1974) 1.26
Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis. Biochem J (1995) 1.26
Quantitative contributions of cholesterol and the individual classes of phospholipids and their degree of fatty acyl (un)saturation to membrane fluidity measured by fluorescence polarization. Biochemistry (1987) 1.25
1-O-hexadecyl-2-Q-methylglycerol, a novel inhibitor of protein kinase C, inhibits the respiratory burst in human neutrophils. J Biol Chem (1989) 1.24
Diacylglycerol kinase is phosphorylated in vivo upon stimulation of the epidermal growth factor receptor and serine/threonine kinases, including protein kinase C-epsilon. Biochem J (1993) 1.20
Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J Clin Invest (1999) 1.19
Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res (1999) 1.18
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol (2003) 1.17
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B. Cell Death Dis (2012) 1.14
Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation. J Biol Chem (1999) 1.10
Diacylglycerol kinase theta binds to and is negatively regulated by active RhoA. J Biol Chem (1999) 1.08
Metabolic conversion of the biologically active phospholipid, lysophosphatidic acid, in fibroblasts. Biochim Biophys Acta (1992) 1.08
Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells. J Natl Cancer Inst (1975) 1.08
Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg (2012) 1.08
Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts. J Biol Chem (1997) 1.07
Cloning of a novel human diacylglycerol kinase (DGKtheta) containing three cysteine-rich domains, a proline-rich region, and a pleckstrin homology domain with an overlapping Ras-associating domain. J Biol Chem (1997) 1.05
CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J Biol Chem (1998) 1.04
Exogenous phospholipase D generates lysophosphatidic acid and activates Ras, Rho and Ca2+ signaling pathways. Curr Biol (1998) 1.03
Changes in membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity. Biochim Biophys Acta (1986) 1.01
Platelet-derived growth factor activation of mitogen-activated protein kinase depends on the sequential activation of phosphatidylcholine-specific phospholipase C, protein kinase C-zeta and Raf-1. Biochem J (1997) 0.99
Diacylglycerol kinase-alpha phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility. Oncogene (2007) 0.98
CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition. J Biol Chem (1997) 0.97
Anticancer therapy and apoptosis imaging. Exp Oncol (2012) 0.94
The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer (2002) 0.94
Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. Int J Radiat Oncol Biol Phys (2001) 0.93
Rigid plasma-membrane-derived vesicles, enriched in tumour-associated surface antigens (MLr), occurring in the ascites fluid of a murine leukaemia (GRSL). Int J Cancer (1979) 0.92
Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein. Eur J Cancer (2004) 0.92
The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis. Radiother Oncol (1998) 0.91
Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. Radiother Oncol (2001) 0.91
Negative regulation of diacylglycerol kinase theta mediates adenosine-dependent hepatocyte preconditioning. Cell Death Differ (2010) 0.91
Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer (2007) 0.91
Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer. Br J Surg (2010) 0.91
Fluorescence polarization measurements on normal and tumour cells and their corresponding plasma membranes. Biochim Biophys Acta (1979) 0.90
Diacylglycerol kinase theta is translocated and phosphoinositide 3-kinase-dependently activated by noradrenaline but not angiotensin II in intact small arteries. Biochem J (2001) 0.89
Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway. Oncogene (2007) 0.89
Diacylglycerol kinase in receptor-stimulated cells converts its substrate in a topologically restricted manner. J Biol Chem (1994) 0.89
Studies on plasma membranes. XIX. Isolation and characterization of a plasma membrane fraction from calf thymocytes. Biochim Biophys Acta (1973) 0.88
Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer (2005) 0.88
Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens. J Biol Chem (2000) 0.87
Lysophosphatidic acid: a novel phospholipid with hormone- and growth factor-like activities. Cold Spring Harb Symp Quant Biol (1992) 0.87
Differences in lipid fluidity among isolated plasma membranes of normal and leukemic lympocytes and membranes exfoliated from their cell surface. Biochim Biophys Acta (1977) 0.87
Hypothesis: ceramide conditionally activates atypical protein kinases C, Raf-1 and KSR through binding to their cysteine-rich domains. Biochem J (1998) 0.87
Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys (2001) 0.86
Specificity of cysteine-rich domains in diacylglycerol kinases and protein kinases C. Biochem J (1998) 0.86
The effect of ionizing radiation on endothelial tissue factor activity and its cellular localization. Thromb Haemost (1995) 0.85
Analysis of N-ras mutations in human cutaneous melanoma: tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis. Recent Results Cancer Res (1995) 0.84
Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. Ann Oncol (2009) 0.84
Distribution and antibody-induced redistribution of a mammary tumor virus-induced and a normal antigen on the surface of mouse leukemia cells. J Natl Cancer Inst (1975) 0.83
Influence of hospital type on outcomes after oesophageal and gastric cancer surgery. Br J Surg (2012) 0.83
Effect of overexpression of a neutral sphingomyelinase on CD95-induced ceramide production and apoptosis. Biochem Biophys Res Commun (2001) 0.83
In vitro and in vivo expression of endothelial von Willebrand factor and leukocyte accumulation after fractionated irradiation. Radiat Res (2000) 0.82
Consensus sequences for ATP-binding sites in protein kinases do not apply to diacylglycerol kinases. Biochem J (1994) 0.82
Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro. Cancer Res (1985) 0.81
Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? Eur J Surg Oncol (2013) 0.81
The essentials of locoregional control in the treatment of gastric cancer. Scand J Surg (2006) 0.81
Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation. Cell Death Differ (2009) 0.81
Steady-state fluorescence polarization data in membranes. Resolution into physical parameters by an extended Perrin equation for restricted rotation of fluorophores. Biochim Biophys Acta (1986) 0.80
Retrieval of spatial information in Nijmegen high and low responders: involvement of beta-adrenergic mechanisms in the nucleus accumbens. Behav Neurosci (2000) 0.80
Radiation nephropathy--the link between functional damage and vascular mediated inflammatory and thrombotic changes. Acta Oncol (2001) 0.80
Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor. Cancer Chemother Pharmacol (2007) 0.80
Catalytic hydrogenation of fatty acyl chains in plasma membranes; effect on membrane lipid fluidity and expression of cell surface antigens. Biochim Biophys Acta (1987) 0.79
Immunofluorescence detection of herpes simplex virus type 1 antigen in cerebrospinal fluid cells of experimentally infected mice. J Neurol Sci (1988) 0.79
Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney. Eur J Cancer (1993) 0.79
Lipid metabolism in fibroblast growth factor-stimulated L6 myoblasts: a receptor mutation (Y766F) abrogates phospholipase D and diacylglycerol kinase activities. Biochim Biophys Acta (1998) 0.78
Radiation-induced apoptosis--the ceramide-SAPK signaling pathway and clinical aspects. Acta Oncol (1998) 0.78
Structural basis and physiological control of membrane fluidity in normal and tumor cells. Subcell Biochem (1988) 0.78
Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. Eur J Surg Oncol (2012) 0.78
Towards prediction and modulation of treatment response. Radiother Oncol (1999) 0.78
Alterations in biosynthesis and homeostasis of cholesterol and in lipoprotein patterns in mice bearing a transplanted lymphoid tumor. Biochim Biophys Acta (1985) 0.77
New physiological functions for drug-transporting P-glycoproteins? Drug Resist Updat (1998) 0.77
Membrane organization determines barrier properties of endothelial cells and short-chain sphingolipid-facilitated doxorubicin influx. Biochim Biophys Acta (2014) 0.76
High and low responders to novelty and mesolimbic noradrenaline: effects of noradrenergic agents on radial-maze performance. Behav Neurosci (2002) 0.76
Membrane fluidity, capping of cell-surface antigens and immune response in mouse leukaemia cells. Br J Cancer (1978) 0.75
Changes in concanavalin A-mediated agglutination of hormone-dependent mouse mammary tumour cells during serial transplantation. Br J Cancer (1980) 0.75
Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging. Clin Med Oncol (2008) 0.75
Regarding Maor et al. IJROBP 41:647-650; 1998. Int J Radiat Oncol Biol Phys (1999) 0.75
Translational research offers individually tailored treatments for cancer patients. Cancer J Sci Am (2000) 0.75
Increased expression of glomerular von Willebrand factor after irradiation of the mouse kidney. Radiat Res (1998) 0.75
Radiation-induced von Willebrand factor release. Blood (1997) 0.75
Accumulation of HDL-like lipoproteins in the plasma low-density fractions of tumor-bearing mice. Biochim Biophys Acta (1985) 0.75
[New insights in the adjuvant treatment of gastric cancer]. Ned Tijdschr Geneeskd (2004) 0.75
[The concomitant use of radiotherapy and chemotherapy for the treatment of solid malignant tumors]. Ned Tijdschr Geneeskd (2002) 0.75
Sphingolipids related to apoptosis from the point of view of membrane structure and topology. Biochem Soc Trans (2001) 0.75